Advertisement

Oncology

Boston-based Dana-Farber Cancer Institute named Scarborough, Maine-based New England Cancer Specialists its first affiliate member in Maine, the institute said Jan. 25. 

Advertisement

Increasing diversity and accessibility to clinical trials is key to closing racial gaps in cancer care, Kathy Giusti and John Carpten, MD, wrote for The Hill Jan. 24.

The University of Texas MD Anderson Cancer Center in Houston and Planegg, Germany-based Eisbach Bio GmbH announced a research collaboration on Jan. 19 dedicated to discovering and developing precision oncology drugs that target synthetic lethal engines.

Advertisement